98 results
Page 2 of 5
425
1ky2 esfhkrdxt3p
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.5
ggqh5 6ii0bvl
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.4
au82eai
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.3
trz 5u4p4sf
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-99.1
wmphdqlv65rjlvnc5klx
12 May 22
Yumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Developments
4:52pm
8-K
EX-99.1
0uxj 0mh6a6
24 Mar 22
Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Developments
4:21pm
8-K
EX-10.1
h3u9buz5eobve5qx1
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
qx3kl6eai
19 Jan 22
Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739
7:42am
8-K
EX-99.1
v5ovb6
15 Nov 21
Yumanity Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
7:42am
8-K
EX-99.2
qp473
10 Nov 21
Regulation FD Disclosure
7:12am
8-K
EX-99.1
ps4 nzk58i6o
12 Aug 21
Yumanity Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Developments
4:21pm
S-8
EX-99.1
mgrdkzkt
7 Jun 21
Registration of securities for employees
4:02pm
S-8
EX-99.2
hd1ngy
7 Jun 21
Registration of securities for employees
4:02pm
8-K
EX-99.1
1l5s 37d6f6b5chwm
13 May 21
Yumanity Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Developments
4:00pm